PDF(Pubmed)
Abstract：
Bone metastases is a common manifestation of advanced malignant tumors. With the recent advances in medical technology, the survival period of patients with malignant tumors is prolonged, and the probability of bone metastases is significantly increased. Approximately 70% to 80% of patients with breast or prostate cancer will eventually develop bone metastases. In addition, thyroid, lung, and kidney carcinomas are all known to cause bone metastases, with a 30% to 40% incidence upon postmortem assessment. Bone metastases often lead to severe pain, pathological fractures, and nerve damage and have become a critical factor affecting the quality of life and life expectancy of cancer patients. Although treatments for bone metastases are diverse, choosing the appropriate treatment is difficult. Both conservative treatment and open surgery have certain drawbacks and may not be appropriate for all patients. Interventional procedures have the advantages of less trauma with quicker recovery and represent a viable alternative. This review provides updates on the progress of research on the interventional treatment of bone metastases and directions regarding relevant further studies.
摘要：
骨转移是晚期恶性肿瘤的常见表现。随着医疗技术的进步，恶性肿瘤患者的生存期延长，骨转移的可能性显著增加。大约70％至80％的乳腺癌或前列腺癌患者最终会发生骨转移。此外,甲状腺，肺，众所周知，肾癌会导致骨转移，验尸后评估的发生率为30％至40％。骨转移通常会导致严重的疼痛，病理性骨折,和神经损伤，并已成为影响癌症患者生活质量和预期寿命的关键因素。虽然骨转移的治疗方法多种多样，选择合适的治疗方法是困难的。保守治疗和开放手术都有一定的缺点，可能并不适用于所有患者。介入程序具有创伤小，恢复快的优点，并且是可行的替代方案。本文对骨转移的介入治疗研究进展及相关的进一步研究方向进行综述。
